Mary Pat Moyer

Title: Mary Pat Moyer: Innovator in Biologic Grafts and Vaccination Technologies

Introduction

Mary Pat Moyer is a distinguished inventor based in San Antonio, TX (US). She has made significant contributions to the fields of biologic grafts and vaccination technologies. With a total of 2 patents, her work focuses on enhancing medical applications that can improve patient outcomes.

Latest Patents

Moyer's latest patents include "Enhanced biologic grafts with packaging apparatuses, and methods of use." This invention discloses an apparatus that features a vessel with a port for fluid introduction and a lyophilized membrane placed within the vessel. The membrane is sealed inside, allowing for reconstitution while maintaining sterility. Another notable patent is the "Oral vaccinia formulation," which relates to methods for generating a safe and effective oral smallpox vaccine. This vaccine utilizes a genetically defective strain of the vaccinia virus, designed to confer immunity through oral delivery. The invention also establishes innovative methods for formulation, packaging, and preclinical testing of the vaccine for safety and efficacy.

Career Highlights

Mary Pat Moyer is currently associated with Incell Corporation, LLC, where she continues to advance her research and development efforts. Her work has the potential to revolutionize the way biologic grafts and vaccines are formulated and delivered.

Collaborations

Moyer collaborates with David Janice, contributing to the innovative projects at Incell Corporation, LLC. Their combined expertise enhances the development of groundbreaking medical technologies.

Conclusion

Mary Pat Moyer's contributions to biologic grafts and vaccination technologies exemplify her commitment to innovation in the medical field. Her patents reflect a dedication to improving health outcomes through advanced scientific research.